Medicine & Health

Christopher J. Dy, MD, an associate professor of orthopedic surgery at the School of Medicine, is the recipient of the 2023 Kappa Delta Young Investigator Award for his research on brachial plexus injuries.

For older adults with clinical depression that has not responded to standard treatments, adding the drug aripiprazole to an antidepressant they’re already taking is more effective than switching from one antidepressant to another, according to a study led by the School of Medicine.

Timothy Miller, MD, PhD, the David Clayson Professor of Neurology at the School of Medicine, has been named a winner of the Rainwater Annual Prize for Outstanding Innovation in Neurodegenerative Disease Research.

School of Medicine researchers have identified a possible treatment strategy for some bone marrow failure syndromes. These syndromes lead to an increased risk of developing dangerous infections, anemia and an increased risk of blood cancers.

Jennie H. Kwon, DO, an assistant professor of medicine at the School of Medicine, has been named head of the Society of Healthcare Epidemiologists of America Research Committee.

William A. Peck, MD, a former executive vice chancellor and dean of the School of Medicine, died peacefully, surrounded by family, Feb. 22 at his home in St. Louis County, Mo. He was 89.

A vast database of cancer genomics knowledge started by Washington University scientists has been named a Global Core Biodata Resource by the Global Biodata Coalition. It’s led by twin brothers Malachi Griffith and Obi Griffith, both associate professors of medicine.

On Feb. 25, the Medical Humanities Program in Arts & Sciences will present the “Forum on Medicine, Race and Ethnicity in St. Louis, Past to Future.” The all-day gathering will feature dozens of speakers and panelists exploring how specific local histories impact the region’s diverse communities.

Software developed at Washington University School of Medicine can predict what happens to complex gene networks when individual genes are disrupted in specific ways.

A $15 million commitment from Washington University benefactors Philip and Sima Needleman will enable the university to leverage its expertise in biomedical discovery to boost drug development via the Needleman Program for Innovation and Commercialization.